To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 102 participants.
Also called NCT06467513
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 102 participants
- Sponsor
- Zhang XIao Mei
- Registry
-
NCT06467513
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06467513. Randomized; triple masking; primary purpose other. Start 2024-01-01 (actual); primary completion 2025-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications
- Condition
- Heart Diseases
- Condition
- Heart Valve Diseases
- Intervention (Drug)
- Esketamine hydrochloride injection
- Lead sponsor
- Zhang XIao Mei
Record details
- Record id
cardio:ct-nct06467513- Content hash
6def3ee340c057bf142070a38e8c35d612a69b61a4dde33e1a6f95b0f12a7f37